Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Myomo Sees Q3 Sales $9.500M-$10.000M vs $12.855M Est

Author: Benzinga Newsdesk | August 11, 2025 03:13pm
Myomo (AMEX:MYO) sees Q3 sales of $9.500 million-$10.000 million vs $12.855 million analyst estimate.

Posted In: MYO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist